Clinical efficacy and safety of rituximab with membranous nephropathy: a meta-analysis

INTRODUCTION: Membranous nephropathy (MN) is an organ-specific autoimmune disease, and its prevalence is increasing. B lymphocytes activated by T cells produce antibodies. CD19+/CD20+ plasma cells may contribute to autoantibody and alloantibody production. Rituximab has been effective in treating MN...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Hongzhen, Li, Hong-Yan, Zhou, Tianbiao, Zhong, Zhiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Systematic Review and Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074182/
https://www.ncbi.nlm.nih.gov/pubmed/37034519
http://dx.doi.org/10.5114/aoms.2020.99899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074182/
https://www.ncbi.nlm.nih.gov/pubmed/37034519
http://dx.doi.org/10.5114/aoms.2020.99899

Ejemplares similares